Data / Federal rules / 2026-04981
Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels
The Health and Human Services Department published this final rule in the Federal Register on March 13, 2026.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025.
Key facts
- Document number
- 2026-04981
- Type
- Final rule
- Action
- Issuance of authorized drug testing panels
- Agency
- Health and Human Services Department
- Published
- March 13, 2026
- Dates
- The current authorized drug testing panels and required report nomenclature remain in effect.
- Pages
- 4
Other documents from the Health and Human Services Department
Everything from the Health and Human Services Department · Published in March 2026
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.